Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears as a minor metadata update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T02:35:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision metadata updated: v3.4.1 added and v3.4.0 removed.
    Difference
    0.0%
    Check dated 2026-02-07T23:31:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Show glossary is now displayed and the page revision is updated to v3.4.0, replacing the prior wording 'Last Update Submitted that met QC Criteria' from v3.3.4. The No FEAR Act data label was changed to 'No FEAR Act data' (To avoid being alerted by small changes, set an alert condition by clicking below.)
    Difference
    0.1%
    Check dated 2026-01-24T07:53:16.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision entry updated to v3.3.4; the previous v3.3.3 revision was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T06:30:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state. Several state location entries were removed and the HHS Vulnerability Disclosure section was deleted.
    Difference
    0.8%
    Check dated 2025-12-19T21:41:35.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    This page shows a minor site update: a new Revision: v3.3.2 was added and the previous Revision: v3.3.1 was removed. The change appears to affect only UI/versioning text and does not modify the study content, eligibility criteria, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T14:18:51.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.